Commentary

Management of adnexal masses in pregnancy


 

References

In general, characteristics that are favorable for spontaneous resolution include masses that are simple in nature by ultrasound and less than 5 cm to 6 cm in diameter.

For women with simple-appearing masses on ultrasound, reimaging can occur during the remainder of the pregnancy at the discretion of the physician or during the postpartum period. All women should be provided with torsion and rupture precautions during the pregnancy (Am J Obstet Gynecol. 2011 Aug;205[2]:97-102). For women with more concerning features on ultrasound, referral to a gynecologic oncologist is warranted. If the decision for surgical management is made, minimally invasive surgery should be strongly considered due to minimal maternal and perinatal morbidity.

Dr. Staley is a resident physician in the department of obstetrics and gynecology at the University of North Carolina at Chapel Hill. Dr. Gehrig is professor and director of gynecologic oncology at the university. They reported having no relevant financial disclosures.

Pages

Recommended Reading

Understanding ovarian germ cell neoplasms
MDedge Hematology and Oncology
Primary care residents’ approach to HPV vaccine vary by specialty
MDedge Hematology and Oncology
Primary small cell cancer of the anus rare, but devastating
MDedge Hematology and Oncology
VIDEO: Should the HPV test be a stand-alone cancer screening test?
MDedge Hematology and Oncology
VIDEO: Is hysterectomy still best for complex atypical hyperplasia?
MDedge Hematology and Oncology
Validated tool outperforms KPS in predicting chemo toxicity in older adults
MDedge Hematology and Oncology
Patients: Intraperitoneal chemotherapy ‘worth it’ for ovarian cancer
MDedge Hematology and Oncology
Novel combination delays progression of recurrent gynecologic tumors
MDedge Hematology and Oncology
ASCO issues clinical practice guidelines for invasive cervical cancer
MDedge Hematology and Oncology
Few locally advanced cervical cancer patients get guideline-directed therapies
MDedge Hematology and Oncology